EATONTOWN, N.J.--(BUSINESS WIRE)--Interim six month clinical results on the use of the FlexStent® Femoropopliteal Self Expanding Stent System in the Superficial Femoral Artery were presented today at the VIVA conference by Dr. William Gray of NY Columbia-Presbyterian Hospital. The clinical results originated from Flexible Stenting Solutions, Inc (“FSS”) first-in-man study conducted in New Zealand by Principle Investigator Dr. Andrew Holden of Auckland City Hospital, and FSS’s supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig – Heart Center.
